BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27075437)

  • 1. LDL-lowering therapy and the risk of prostate cancer: a meta-analysis of 6 randomized controlled trials and 36 observational studies.
    Tan P; Wei S; Tang Z; Gao L; Zhang C; Nie P; Yang L; Wei Q
    Sci Rep; 2016 Apr; 6():24521. PubMed ID: 27075437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of statins type on incident prostate cancer risk: a meta-analysis and systematic review.
    Tan P; Zhang C; Wei SY; Tang Z; Gao L; Yang L; Wei Q
    Asian J Androl; 2017; 19(6):666-671. PubMed ID: 27924788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies.
    Bonovas S; Filioussi K; Sitaras NM
    Int J Cancer; 2008 Aug; 123(4):899-904. PubMed ID: 18491405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Statins on the Risk of Different Stages of Prostate Cancer: A Meta-Analysis.
    Li Y; Cheng X; Zhu JL; Luo WW; Xiang HR; Zhang QZ; Peng WX
    Urol Int; 2022; 106(9):869-877. PubMed ID: 34518476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of antioxidant vitamins and selenium supplement in prostate cancer prevention: a meta-analysis of randomized controlled trials.
    Jiang L; Yang KH; Tian JH; Guan QL; Yao N; Cao N; Mi DH; Wu J; Ma B; Yang SH
    Nutr Cancer; 2010; 62(6):719-27. PubMed ID: 20661819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin use and risk of pancreatic cancer: a meta-analysis.
    Cui X; Xie Y; Chen M; Li J; Liao X; Shen J; Shi M; Li W; Zheng H; Jiang B
    Cancer Causes Control; 2012 Jul; 23(7):1099-111. PubMed ID: 22562222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uricosuric medications for chronic gout.
    Kydd AS; Seth R; Buchbinder R; Edwards CJ; Bombardier C
    Cochrane Database Syst Rev; 2014 Nov; (11):CD010457. PubMed ID: 25392987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin use and the risk of prostate cancer: a meta-analysis of 24 epidemiologic studies.
    Huang TB; Yan Y; Guo ZF; Zhang XL; Liu H; Geng J; Yao XD; Zheng JH
    Int Urol Nephrol; 2014 Sep; 46(9):1715-28. PubMed ID: 24687637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin Use and the Risk of Cataracts: A Systematic Review and Meta-Analysis.
    Yu S; Chu Y; Li G; Ren L; Zhang Q; Wu L
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28320745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin use and non-melanoma skin cancer risk: a meta-analysis of randomized controlled trials and observational studies.
    Yang K; Marley A; Tang H; Song Y; Tang JY; Han J
    Oncotarget; 2017 Sep; 8(43):75411-75417. PubMed ID: 29088876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis.
    Bosco C; Bosnyak Z; Malmberg A; Adolfsson J; Keating NL; Van Hemelrijck M
    Eur Urol; 2015 Sep; 68(3):386-96. PubMed ID: 25484142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between shift work and risk of prostate cancer: a systematic review and meta-analysis of observational studies.
    Gan Y; Li L; Zhang L; Yan S; Gao C; Hu S; Qiao Y; Tang S; Wang C; Lu Z
    Carcinogenesis; 2018 Feb; 39(2):87-97. PubMed ID: 29126152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies.
    Qiao Y; Yang T; Gan Y; Li W; Wang C; Gong Y; Lu Z
    BMC Cancer; 2018 Mar; 18(1):288. PubMed ID: 29534696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and risk factors of suicide after a prostate cancer diagnosis: a meta-analysis of observational studies.
    Guo Z; Gan S; Li Y; Gu C; Xiang S; Zhou J; Gong L; Chan FL; Wang S
    Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):499-508. PubMed ID: 30108374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between Selenium and Prostate Cancer: a Systematic Review and Meta-Analysis.
    Sayehmiri K; Azami M; Mohammadi Y; Soleymani A; Tardeh Z
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1431-1437. PubMed ID: 29936712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin use and risk of prostate cancer: a meta-analysis of observational studies.
    Bansal D; Undela K; D'Cruz S; Schifano F
    PLoS One; 2012; 7(10):e46691. PubMed ID: 23049713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins are associated with reduced risk of gastric cancer: a meta-analysis.
    Wu XD; Zeng K; Xue FQ; Chen JH; Chen YQ
    Eur J Clin Pharmacol; 2013 Oct; 69(10):1855-60. PubMed ID: 23748751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total Calcium (Dietary and Supplementary) Intake and Prostate Cancer: a Systematic Review and Meta-Analysis.
    Rahmati S; Azami M; Delpisheh A; Hafezi Ahmadi MR; Sayehmiri K
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1449-1456. PubMed ID: 29936714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can statins reduce risk of lung cancer, especially among elderly people? A meta-analysis.
    Deng Z; Zhang S; Yi L; Chen S
    Chin J Cancer Res; 2013 Dec; 25(6):679-88. PubMed ID: 24385695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis.
    Etminan M; FitzGerald JM; Gleave M; Chambers K
    Cancer Causes Control; 2005 Nov; 16(9):1125-31. PubMed ID: 16184479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.